From time to time the CHS collaborates with market research companies. We believe that market studies can provide valuable information to companies on how to improve their products and services.

The CHS is helping with the publicizing of this market research opportunity to chapters, but is not providing any information about members.

Keep your eyes open for postings about future market research studies.



Calling all men with hemophilia B, aged 18 years or older, treated with Rebinyn

     Invitation for patients in ALL provinces except Alberta and Newfoundland and Labrador

     Invitation for Alberta patients

     Invitation for Newfoundland and Labrador patients



Kantar Health, a market research firm specializing in medical research, is currently recruiting people with hemophilia A to take part in an online survey. This survey is hoping to gain clarity on how people with hemophilia A define activity and the impact of treatment on their daily lives.

Potential participants must meet the following criteria:

  • At least 18 years of age
  • Diagnosed with moderate or severe hemophilia A (or caregiver of a child diagnosed with moderate or severe hemophilia A)
  • Not currently diagnosed with clinically significant inhibitors
  • Currently manage their condition with prophylaxis or on demand treatment

In order to participate in the survey, please click on the following link:

The survey will take approximately 25 minutes to complete online. Participation is strictly voluntary and there are no right or wrong answers.

All participants who complete the survey will receive a compensation of $92.00 by mailed check.

Please note that all responses will be kept strictly confidential and will be presented in aggregate with those of other participants.